Normally Developing Pregnancy and Hydatidiform Mole: A Case Report-Reference-Cited by-同舟云学术

Normally Developing Pregnancy and Hydatidiform Mole: A Case Report

Published:2024-08-23 Issue:3 Volume: Page:84-90
ISSN:2541-9897
Container-title:Innovative Medicine of Kuban
language:
Short-container-title:Innovacionnaâ medicina Kubani

Author:

Peredvigina A. V.¹^ORCID,Semenova M. V.²^ORCID,Talabadze A. S.²^ORCID,Serova M. V.³^ORCID,Sakhabutdinova E. P.³^ORCID,Fedorova I. V.⁴^ORCID,Sencha A. N.⁵^ORCID

Affiliation:

1. National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov

2. Izhevsk State Medical Academy

3. First Republican Clinical Hospital

4. Republican Pathoanatomical Bureau of the Ministry of Health of the Udmurt Republic

5. National Medical Research Center for Obstetrics, Gynecology, and Perinatology named after Academician V.I. Kulakov; Pirogov Russian National Research Medical University

Abstract

Introduction: Hydatidiform mole with a normally developing fetus is a rare case associated with an increased risk of bleeding, preterm birth, preeclampsia, congenital anomalies, and intrauterine fetal death.Case report: We report a case of a twin pregnancy with a hydatidiform mole and a normal fetus. The pregnancy was conceived via in vitro fertilization. The complete hydatidiform mole was diagnosed during the first screening. We extended the pregnancy until 38 weeks’ gestation. Thanks to the control of beta-human chorionic gonadotropin levels and dynamic ultrasound monitoring, the woman successfully gave birth.

Publisher

Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1

Reference23 articles.

1. Clinical Guidelines – Trophoblastic Neoplasms – 2020-2021- 2022 (January 31, 2023) – Approved by the Ministry of Health of the Russian Federation. Accessed February 10, 2024. (In Russ.). https://disuria.ru/_ld/13/1351_kr20C58MZ.pdf

2. Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol. 2003;4(11):670–678. PMID: 14602247. https://doi.org/10.1016/s1470-2045(03)01245-2

3. Ngan HYS, Seckl MJ, Berkowitz RS, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021;155 Suppl 1(Suppl 1):86–93. PMID: 34669197. PMCID: PMC9298230. https://doi.org/10.1002/ijgo.13877

4. Ozalp SS, Yalcin OT, Tanir HM. Hydatidiform mole at extreme ages of reproductive life in a developing country from 1932 to 2000. Eur J Gynaecol Oncol. 2002;23(4):361–362. PMID: 12214746.

5. Fisher RA, Maher GJ. Genetics of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2021;74:29–41. PMID: 33685819. https://doi.org/10.1016/j.bpobgyn.2021.01.004